Skip to search formSkip to main contentSkip to account menu

Oviol

Known as: 19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17alpha)-, mixt. with (17alpha)-13-ethyl-11-methylene-18,19-dinorpregn-4-en-20-yn-17-ol 
National Institutes of Health

Related topics

Related topics

12 relations
CTR 24Desogen (contraceptive)MircetteOvidol

Broader (5)

Combined Oral ContraceptivesDesogestrelDesogestrel / Ethinyl EstradiolEthinyl Estradiol

Narrower (1)

Desogestrel 0.15 MG / Ethinyl Estradiol 0.03 MG Oral Tablet

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
Transport behaviour of volatile chlorinated hydrocarbons in a soil/groundwater system
The transport behaviour of selected volatile chlorinated hydrocarbons (VCH), namely chloroform, trichloroethane… 
1987
1987
[Side effects of hormonal contraception. Experiences with 1,702 patients and 17,228 cycles].
During 25 years 1,702 women with 17,228 cycles under oral contraceptive were observed. This report covers 1,021 women with 11,648… 
1984
1984
[Comparison of a 2-phase preparation (Oviol 22) with a low-dose 1-phase preparation (Ovoresta M)].
Oviol 22 was administered to 145, and Ovoresta M to 118 healthy female volunteers. During the first six cycles, 27 (18.6%) women… 
1982
1982
Effect of hormonal contraceptives containing 0.05 mg ethinyl estradiol and 0.125 mg desogestrel in normophasic regimen (Oviol)
This evaluation is based on data obtained from a multicenter trial of 953 women who have used the tested oral contraceptive (OC… 
1982
1982
[Effect of hormonal contraceptives containing 0.05 mg ethinyl estradiol and 0.125 mg desogestrel in normophasic regimen (Oviol)].
This evaluation is based on data obtained from a multicentre trial in which to date 953 women have used the tested oral…